ライフサイエンスコーパス: hospital stay

1 practice (0.74% for office visits; 0.51% for hospital stays).

2 as associated with longer duration of MV and hospital stay.

3 dmission to hospital and potential length of hospital stay.

4 d reported mortality and/or length of ICU or hospital stay.

5 ostoperative ileus, anastomotic leakage, and hospital stay.

6 robial agents divided by the total length of hospital stay.

7 sistant organism colonisation; and length of hospital stay.

8 tibiotic classes, and length of preoperative hospital stay.

9 orter time in the recovery unit, and shorter hospital stay.

10 ric oxide for at least 24 hours during their hospital stay.

11 (17%) assigned to standard care died during hospital stay.

12 n ICD or had one planned for placement after hospital stay.

13 ICU-acquired muscle weakness extends beyond hospital stay.

14 the same time point, and delirium during the hospital stay.

15 ion of mechanical ventilation, and length of hospital stay.

16 stula (grade B/C), mortality, morbidity, and hospital stay.

17 the surgical group during the postoperative hospital stay.

18 nsive care unit admission, transfusions, and hospital stay.

19 23 were readmitted, and one had a prolonged hospital stay.

20 2) once daily for the entire duration of the hospital stay.

21 nd a 24% reduction, respectively, in cost of hospital stay.

22 (95% CI, 22.2-213.1) for not surviving their hospital stay.

23 than conservative treatment with comparable hospital stay.

24 ital complications, intensive care unit, and hospital stay.

25 tive pain, complications, QoL, and length of hospital stay.

26 eatment with fondaparinux or LMWH during the hospital stay.

27 ion of mechanical ventilation, ICU stay, and hospital stay.

28 moderate pancreatitis, may reduce length of hospital stay.

29 atory distress syndrome and pneumonia during hospital stay.

30 uring the emergency department and inpatient hospital stay.

31 ncy, and increases morbidity and duration of hospital stay.

32 ns, hospital mortality, and median length of hospital stay.

33 es, antimicrobial stewardship, and length of hospital stay.

34 ous ammonia, time of recovery, and length of hospital stay.

35 ore meals (the basal-bolus group) during the hospital stay.

36 pendent risk factor for mortality and longer hospital stay.

37 ratio, 0.62; 95% CI, .29-1.36) nor length of hospital stay.

38 sk of pulmonary embolism and required longer hospital stay.

39 MDROs on morbidity, mortality, and length of hospital stay.

40 MIE was associated with a shorter hospital stay.

41 differences in complications, and length of hospital-stay.

42 BCs had a higher reoperation rate and longer hospital stays.

43 mechanical ventilation, or lengths of ICU or hospital stays.

44 t invasive devices, and mortality and longer hospital stays.

45 n survivors was also associated with shorter hospital stays.

46 nd intensive care unit admission and shorter hospital stays.

47 odds ratio [aOR], 1.97; P = .01) and longer hospital stay (1.34; P < .001).

48 gery (02:29 vs 02:47 hrs, P = 0.17) and mean hospital stay (10 +/- 7.1 vs 8 +/- 3.7 days, P = 0.11) d

49 Univariate analysis revealed shorter hospital stay (11 +/- 15 d vs 7 +/- 10 d; p = 0.02) and

50 t stay (151 vs 117 hours; P < .001), but not hospital stay (11 vs 12 days; P = .50), was longer in th

51 6%] patients; P < .001) and longer mean (SD) hospital stays (11.3 [14.6] vs 5.1 [8.8] days; P < .001)

52 43 [2.8%]; P < .001) and prolonged length of hospital stay (12 vs 8 days; P = .04).

53 ration (16.6% vs 21.0%; P = 0.22), length of hospital stay (12.2 vs 12.2; P = 0.99) and rate of stoma

54 ions (odds ratio 1.51, P = 0.002) and longer hospital stays (+12%, P = 0.006).

55 ions (odds ratio 1.51, P = 0.002) and longer hospital stays (+12%, P = 0.006).

56 8 vs 10.1 d; p < 0.001), duration of ICU and hospital stay (15.5 vs 12.2 d; p < 0.001 and 28.0 vs 24.

57 analysis (0.7% vs 1.2%, P = 0.05), a shorter hospital stay (15.8 +/- 0.6 vs 17.8 +/- 0.55, P = 0.0053

58 ity (5.3% vs 1.0%), and longer postoperative hospital stays (17.9 days vs 3.6 days).

59 8.1 +/- 8.5 vs. 9.4 +/- 7.4 h) and length of hospital stay (19.7 +/- 27.8 vs. 23.5 +/- 34.4 h) were s

60 The overall hospital stay (2.8 days vs. 4.1 days, p < 0.0001) and co

61 peratively were more likely to have a longer hospital stay (2.9 d vs. 2.5 d, P <0.001) and were more

62 , 1.3 to 12.0 percentage points]), overnight hospital stays (2.4 percentage points [CI, 0.7 to 4.2 pe

63 Ambulatory Medical Care Surveys) and 108472 hospital stays (2010 National Hospital Discharge Survey)

64 ys vs. 28 days), as was the median length of hospital stay (21 days vs. 33 days) (P<0.001 for both co

65 0 [SD, 13.3] years; 91 women [56.9%]; median hospital stay, 21 days) and 94 caregivers, 157 (98.1%) a

66 .001), ICU stay (12 vs 8 d; p < 0.0001), and hospital stay (24 vs 15 d; p < 0.0001).

67 14.1% (95% CI, 13.3%-15.0%), and during the hospital stay, 24.6% (95% CI, 23.5%-25.7%).

68 antibiotics of varying duration during their hospital stay, 2845 were diagnosed as having sepsis-rela

69 d for 30-day and 90-day mortality, length of hospital stay, 30-day unplanned readmission rate, and ma

70 There was no difference in hospital stay: 4 days (interquartile range: 3-5 days) in

71 cy Unit (2 vs. 6 days, P = 0.001), and total hospital stay (5 vs. 8 days, P = 0.001) were observed af

72 (33%) vs 35 (54%); P = 0.029] but a similar hospital stay [5 days (IQR, 4-8 days) vs 7 days (IQR, 4.

73 0]; difference, -18 days [95% CI, -41 to 4]; hospital stay: 51 days [Q1, Q3: 31, 74] in the early gro

74 duration of ventilation, duration of ICU and hospital stay, 6-month recurrence, and rehospitalization

75 [CI]: 1.3-8.5) and a longer median length of hospital stay (7 vs 12 days, P < 0.001).

76 Twelve percent (n = 333) died during their hospital stay, 8.1% (n = 222) of patients died postdisch

77 ry (59.9% vs 15.4%), had longer preoperative hospital stays (9.1 days vs 1.9 days), and had received

78 ission, and discharge destination) and cost (hospital stay, 90-, 180-, and 365-d) after adjusting for

79 .70; 95% CI, 2.27-3.22; P < .001) and longer hospital stay (adjusted multiplicative difference, 2.14;

80 4.6 (95% CI=2.5-8.3); p=<0.0001], and longer hospital stay [adjusted parameter estimate 8.8 days (95%

81 of the primary outcome, durations of ICU and hospital stay, adverse events, and all-cause mortality a

82 Length of hospital stay after birth (P = .002) and maternal coloni

83 anical ventilation, death, or termination of hospital stay against medical advice) after more than 1

84 mean duration of mechanical ventilation and hospital stay also did not demonstrate incrementally gre

85 Average length hospital stay amounted to 2.9 days.

86 to a stroke unit at some point during their hospital stay and 21% were cared for in a general ward.

87 with increased morbidity including length of hospital stay and an increased incidence of resistant in

88 were measured at admission and on 3rd day of hospital stay and compared with the control group.

89 impairment associated with longer length of hospital stay and cost, premature withdrawal from the wo

90 sion (LTP), postoperative complications, and hospital stay and fee between the two groups.

91 me hospitals was LPD associated with shorter hospital stay and lower readmission compared with OPD.

92 mplications have increased risk of prolonged hospital stay and mortality.

93 vage group; whereas, length of postoperative hospital stay and quality of life did not differ signifi

94 fferent NIs to predict outcomes of length of hospital stay and readmission to refine the detection of

95 bust reduction in morbidity and length of in-hospital stay and some reduction in mortality.

96 The length of hospital stay and the complication rate were not signifi

97 gnoses of acute myocardial infarction during hospital stay and their associated fatality rates (durin

98 for association with two outcomes: length of hospital stay and time to all-cause hospital readmission

99 We assessed temporal trends in length of hospital stay and use of pharmacological and interventio

100 The patient had an uneventful postoperative hospital stay and was asymptomatic on a follow-up five m

101 tment groups had similar intensive care unit/hospital stays and high reintervention rates in the firs

102 outcome, including intensive care unit stay, hospital stay, and 1 year mortality between the two grou

103 nty-seven patients (26.0%) died during their hospital stay, and 24 of them had positive (18)F-FDG PET

104 , need for mechanical ventilation, length of hospital stay, and 30-day mortality.

105 ality, 30-day all-cause mortality, length of hospital stay, and 30-day readmission rate among patient

106 s significantly reduce septic complications, hospital stay, and antibiotic requirement in patients un

107 first rank to reduce SSI, pneumonia, sepsis, hospital stay, and antibiotic use.

108 high ESBL-EC colonization pressure, extended hospital stay, and close contact between patients may se

109 milar to CTA in time to diagnosis, length of hospital stay, and cost, with improved prognostic accura

110 d with less overall morbidity, shorter total hospital stay, and duration of antibiotic therapy, as we

111 d with increased hospitalizations, prolonged hospital stay, and escalation of care.

112 endency and increases morbidity, duration of hospital stay, and health care costs.

113 nical ventilation, intensive care unit stay, hospital stay, and highest primary graft dysfunction sco

114 be, length of mechanical ventilation and ICU/hospital stay, and hospital mortality were higher in pat

115 ubsequent ICU admission, increased length of hospital stay, and increased hospital mortality.

116 e and retrospectively medical comorbidities, hospital stay, and infectious complications.

117 er function tests, intensive care unit stay, hospital stay, and morbidity (greater than Clavien II) w

118 raphics, clinical characteristics, length of hospital stay, and mortality.

119 d findings, injury severity score, length of hospital stay, and number of mortalities.

120 Charlson Comorbidity Index score, length of hospital stay, and number of outpatient visits.

121 ographics, medications, diagnoses, length of hospital stay, and out-of-pocket drug costs as covariate

122 icated appendicitis, postoperative length of hospital stay, and overall duration of postoperative ant

123 h of operating time, length of postoperative hospital stay, and quality of life.

124 nd mortality, rate of reoperation, length of hospital stay, and rate of stoma closure at 6 months.

125 operative morbidity and mortality, length of hospital stay, and readmission rate.

126 ra-abdominal abscess, reoperation, length of hospital stay, and readmission.

127 ra-abdominal abscess, reoperation, length of hospital stay, and readmission.

128 The primary endpoint was length of hospital stay, and secondary endpoints were test feasibi

129 Procedural time, length of postoperative hospital stay, and the rate of intra- and postoperative

130 ntified, including advanced age, a prolonged hospital stay, and use of acid-suppressive drugs.

131 ity, hospital-acquired infections, length of hospital stay, and ventilator-free days, using multivari

132 GA5 infections were associated with longer hospital stay, and with less activation of interferon an

133 ource utilization: emergency room visits and hospital stays, and (4) total annual and out-of-pocket h

134 e interval, 1.01-1.80), significantly longer hospital stays, and a lower probability of being dischar

135 d with adverse neurological outcomes, longer hospital stays, and increased in-hospital mortality.

136 higher mortality, greater disability, longer hospital stays, and lower chance of being discharged hom

137 excess in the number of inpatient cases and hospital stays, and problems with delivering continuity

138 ss, pyogenic arthritis, tuberculosis, longer hospital stays, and/or ICU/NICU admission.

139 points included adverse events, duration of hospital-stay, and 3-year outcomes.

140 reduced pulmonary complications and shorter hospital stay as compared to OE.

141 e delirium incidence and severity during the hospital stay, as assessed by the Confusion Assessment M

142 ion had a serious adverse event during their hospital stay, as did 28 (29%) who received standard car

143 95 patients (57.0%) who survived the initial hospital stay at a mean (SD) of 5.2 (2.9) years after EV

144 The recorded outcomes were length of hospital stay, bacterial infection, rebleeding, and in-h

145 stically significant difference in length of hospital stay between children receiving beta-lactam mon

146 ation increased out-of-bed activities during hospital stay but did not improve outcomes.

147 o frequency of reoperations or the length of hospital stay, but use of HES 130/0.4 was both more expe

148 increased mortality and morbidity and longer hospital stays, but data on the burden of S aureus disea

149 protocols have resulted in shorter length of hospital stay by 30% to 50% and similar reductions in co

150 hanical ventilation by approximately 5%, and hospital stay by approximately 1 day.

151 Patients were followed during their hospital stay by daily registration of wards and patient

152 e hospitalized and had significantly shorter hospital stays compared with infants born to unvaccinate

153 he percentages of office visit conditions or hospital stay conditions seen were less than the applica

154 Total length of hospital stay (days) within 12 months was shorter for th

155 y outcome measures were mortality, length of hospital stay, days in intensive care unit, and duration

156 The median hospital stay declined over the years for both procedure

157 Risk-adjusted mean hospital stay decreased by 8.6%, representing nearly 100

158 The median length of hospital stay decreased from 12 days (IQR 7-18) in 2001

159 fter implementation of the policy, length of hospital stay decreased more than expected from the base

160 n patients without ACS, the median length of hospital stays decreased by 2.9 hours (95% confidence in

161 ions, hospital readmissions, total length of hospital stay during 12 months, and adverse events.

162 al complications, reinterventions, prolonged hospital stay [endovascular aneurysm repair (EVAR) </=4

163 ransfusion, and is associated with a shorter hospital stay, enhanced restoration of iron stores, and

164 ; 95% CI = 1.02-1.82; P = .04) and prolonged hospital stay (estimate = 2.91; SE = 0.44; P < .001).

165 roblem within hospitals, leading to extended hospital stays, excess morbidity and mortality, and econ

166 omparable complication rate during the index hospital stay for DCD and DBD LT, but the CCI increases

167 l admission is associated with lower cost of hospital stay for patients admitted with an advanced can

168 The mean hospital stay for the moderate group was 12.4 days vs 10

169 n in practice during either office visits or hospital stays for each of 186 condition categories (eg,

170 The laparoscopic approach shortened hospital stay from 0.16 to 1.13 days in seven out of eig

171 e survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratifi

172 ars, male sex, BMI >/=50 kg/m, postoperative hospital stay >/=3 days, and operative time >/=3 hours.

173 Conversely, hospital stay >7 days (OR, 0.56; 95% CI, 0.51-0.62) and

174 [95% CI, 1.38-1.42]) and prolonged length of hospital stay (>6 days) among both women with cesarean d

175 responses, while individuals with prolonged hospital stays have late recruitment of CD8(+)/CD4(+) T

176 severe sepsis, with higher median length of hospital stay (hospital acquired [17 d] vs healthcare as

177 s after discharge from the ICU for length of hospital stay, hospital mortality, and 6-month mortality

178 which was assumed to affect per-patient per-hospital-stay ICU cost and hospital mortality.

179 erences in the length of ICU stay, length of hospital stay, ICU mortality, and in-hospital mortality.

180 cessary antibiotic use, shortening length of hospital stay, improving influenza detection and treatme

181 al trial with data collection during a brief hospital stay in a tertiary care, community teaching hos

182 Donor median hospital stay in both groups was identical [LDLT <50: 6

183 ratio, 3.81; 95% CI, 1.66-8.75), and median hospital stay in patients discharged alive was longer (1

184 piratory, renal complications, and length of hospital stay in patients undergoing elective AAA repair

185 e I to III complications (6.4) or across the hospital stay in patients without complications (5.4; P

186 andomized trials showed significantly longer hospital stay in the antibiotic treatment group (RR 0.3

187 day (95% CI, 1.3-2.03; p = 0.02) decrease in hospital stay in the postintervention group.

188 associated with lower mortality and shorter hospital stays in patients with severe sepsis or septic

189 Length of ICU and hospital stay increased with more severe sepsis.

190 er failure (LF) is associated with prolonged hospital stay, increased cost and substantial mortality.

191 major surgery and is associated with longer hospital stays, increased hospital costs, and 1-year mor

192 ength of intensive care unit stay, length of hospital stay, inotropic support, and survival.

193 No difference was observed in mean hospital stay, intensive care unit (ICU) days, or ventil

194 were younger than 18 years, had a length of hospital stay less than 2 days, or had preexisting deep

195 for associations between age, sex, length of hospital stay, level of education, income, comorbidity,

196 ures and clinical variables [e.g., length of hospital stay (LOS) and infection rates].

197 well nutritional variables predict length of hospital stay (LOS) in patients receiving ERAS protocols

198 ng Tool (MUST) and its relation to length of hospital stay (LOS) in the general hospital population a

199 Outcome measures were a length of hospital stay (LOS) of >/=3 days and intensive care use,

200 dity, (iii) transfusion rate, (iv) length of hospital stay (LOS), and (v) long-term survival.

201 volume per standard liver volume, length of hospital stay (LOS), complications, and readmissions.

202 uries (AIS >/= 3), death within 72 hours, or hospital stay <48 hours were excluded.

203 t effect of NIs on the outcomes of length of hospital stay (<7 d and >/=7 d) and readmission within 3

204 .90), sepsis (RR = 0.09; 95% CI, 0.01-0.94), hospital stay (mean = 9.66 days, 95% CI, 7.60-11.72), an

205 interval, 0.50-0.88; P=0.005) and unplanned hospital stay (median, 0.22 [interquartile range, 0-1.3]

206 e, -12 hours; 95% CI, -21 to 2; P=0.09), and hospital stay (median, 14 days and 14 days, respectively

207 These patients also experienced reduced hospital stay (median: 8 days vs 9 days, P = 0.001).

208 rdion grade >/=3, 23.05% vs 23.7%; P > .99), hospital stay (median: 8 vs 8.5 days; P = .31), 30-day r

209 d: all readmission episodes (within the same hospital stay), missing in-hospital mortality, admission

210 t within 8 weeks (150.56 [73.11 to 310.06]), hospital stay more than 3 days before sampling (2.34 [1.

211 has major public health implications-longer hospital stay, more frequent hospital admissions, greate

212 To compare length of hospital stay, mortality, and readmission in adults hosp

213 anges in criteria for coverage for inpatient hospital stays, most nonacute percutaneous coronary inte

214 rity is independently associated with longer hospital stays, nursing home placement, and death in pat

215 More blood loss and longer hospital stays occurred in the fusion group than in the

216 of acute illness burden, including length of hospital stay (odds ratio [OR], 1.02 [95% CI, 1.00 to 1.

217 years (OR = 1.2, 95% CI; 1.1-1.3), length of hospital stay of >7 days (OR = 1.1, 95% CI; 1.02-1.2), m

218 room, except 1 (2.6%) patient, after a mean hospital stay of 8.4 hours +/- 6.9 hours.

219 A hospital stay of less than 48 hours for routine supporti

220 Hospital stays of all donors were 6 days and median sick

221 missions and shorter intensive care unit and hospital stays of longer than 4 days (all P < .05).

222 For concordance between questions and hospital stays only, 1456 questions (42.07%; 95% CI, 40.

223 ving is also feasible if the per-patient per-hospital-stay operational cost and physician cost were l

224 he likelihood of a doctor visit or overnight hospital stay or health status as reported by the respon

225 CI, 2.12 to 9.29; P < .001) and have shorter hospital stays (OR, 0.84; 95% CI, 0.77 to 0.91; P < .001

226 .08; 95% CI, 3.46 to 7.45; P < .001), longer hospital stays (OR, 1.15; 95% CI, 1.11 to 1.20; P < .001

227 equiring coronary revascularization, shorten hospital stay, or allow for more direct discharge from t

228 age-adjusted haemoglobin values, duration of hospital stay, or any other laboratory markers of inflam

229 and night shift, but not with sex, length of hospital stay, or hospital unit.

230 invasive ventilatory support, the length of hospital stay, or the 30-day mortality in patients with

231 cation of disease and a major determinant of hospital stay outcome.

232 Patients with delirium had longer length of hospital stay (P < 0.001) and greater likelihood of disc

233 ntibiotics therapy (P < 0.05), and length of hospital stay (P < 0.05) were significantly lower in the

234 tion (but not NPA) correlated with length of hospital stay (P = .04) and requirement for mechanical v

235 s severe complications (P < 0.001), 25% less hospital stay (P = 0.013), and 65% less ICU stay (P < 0.

236 P = 0.480), wound infection (P = 0.758), and hospital stay (P = 0.487) did not show significant diffe

237 imary graft dysfunction score (P = 0.67) and hospital stay (P = 0.99).

238 artum antibiotics (0.8, 0.7-1.0), and longer hospital stay (p<0.0001), but a lower risk of caesarean

239 t therapy (P=0.04) and a shorter duration of hospital stay (P=0.001).

240 0.89; p=0.0250), and 1-day shorter length of hospital stay (p=0.0091).

241 d warm ischemia times, blood loss, length of hospital stay, pain score, convalescence, quality of lif

242 lactate, intensive care unit stay, length of hospital stay, peak glucose, inotropic dose, graft dysfu

243 ls also had substantially shorter lengths of hospital stay, perhaps reflecting more efficient postope

244 no significant differences in complications, hospital stay, perioperative mortality, or median surviv

245 Overall complications, hospital stay, perioperative vasopressor requirements, a

246 bations, ICU readmissions, prolonged ICU and hospital stay, persistent cognitive problems, and higher

247 More cardiac surgeries, longer hospital stay, poorer linear growth, and tube feeding we

248 The median length of hospital stay post transplant was also similar across gr

249 obstacles for achieving TO were a prolonged hospital stay, postoperative complications, and readmiss

250 lude length of Intensive Care Unit (ICU) and hospital stay, postoperative liver function tests, fatty

251 deficits was associated with posttransplant hospital stay (r = 0.34, P = 0.04), but not with delisti

252 including maternal weight gain, duration of hospital stay, readmission rate, nausea and vomiting sym

253 Hospital stay, recurrences, additional interventions, an

254 dy participated in the trial during the same hospital stay, refusing to participate, or having do-not

255 ions (right: 15 [14%] and left: 4 [7%]), and hospital stay (right: 5 days [IQR, 4-7 days] and left: 4

256 ed, pain intensity until POD 10, duration of hospital stay, satisfaction with the aesthetic result, a

257 Data on length of hospital stay, sick leave, socioeconomic parameters, and

258 Most VTEs occur after hospital stay; still a few patients receive extended pha

259 duration of treatment and shorter length of hospital stay than treatment with oral morphine, with si

260 ndary clinical end points were the length of hospital stay, the percentage of infants who required su

261 lustering analysis using data from patients' hospital stays to retrospectively identify patient subgr

262 < 1.000/0.258), and the median postoperative hospital stay (TVAE: 3 d vs TGAE: 3 d; P < 0.152) were c

263 including increased healthcare costs, longer hospital stays, unnecessary consultations, and inappropr

264 l ventilation, intensive care unit stay, and hospital stay until discharge were 1 day, 5.5 days, and

265 Secondary outcomes were length of ICU and hospital stay; ventilator-free days through day 28; pneu

266 Median (IQR) ICU and hospital stay was 0 (0-2) and 12 (9-18) days, respective

267 Hospital stay was 1.4 d longer among undernourished pati

268 The median (range) postoperative hospital stay was 10 (5-105) days for IMN and 10 (6-27)

269 The median in-hospital stay was 10 (range 6-14) days.

270 Median hospital stay was 16 days (range = 11-62).

271 Median hospital stay was 3.0 days, and the overall major advers

272 Mean length of hospital stay was 4.2 days (range, 3-7 days).

273 The median length of hospital stay was 6 days for all strategies, and the med

274 The mean length of hospital stay was 6.4+/-7.3 days with a mean+/-SD cost o

275 The median hospital stay was 8 days.

276 Shorter hospital stay was associated with preoperative carbohydr

277 Median hospital stay was shorter after MIE (14 vs 13 days, P =

278 Overall, hospital stay was shorter after MIG compared with OG (8

279 Length of hospital stay was shorter after training (9 [7-12] vs 7

280 6 vs 29.3%, n = 56; P = .001), and length of hospital stay was significantly reduced (4.6 days post-C

281 Mean hospital stay was significantly shorter in the early-fed

282 Duration of hospital stay was significantly shorter in the exercise

283 The median postoperative length of hospital stay was significantly shorter in the laparosco

284 Length of hospital stay was the primary outcome.

285 sociated with increased mortality and longer hospital stay, we analyzed the Assessment of Worldwide A

286 During their hospital stay, we observed consistently lower CBFi and C

287 Median intensive care unit and hospital stay were 2 and 9 days, respectively.

288 Morbidity, mortality, and hospital stay were evaluated.

289 No differences in PICU or hospital stay were observed across the groups.

290 low-up, 218 patients died and 17 917 days of hospital stay were recorded.

291 Venous ammonia at day 5 and length of hospital stay were significantly lower in the LOLA group

292 Duration of RRT and length of hospital stay were significantly shorter in the early gr

293 Intensive care and hospital stays were significantly more prolonged in the

294 METHODS/Ninety-one patients died during the hospital stay while 92 patients from the 493 individuals

295 ousal domains were associated with length of hospital stay, while the negative valence and social dom

296 s significant lower morbidity, and a shorter hospital stay with comparable oncological outcomes when

297 of camels, poor hand hygiene, and overnight hospital stays with respiratory complaints.

298 tions seen in 13832 office visits and 108472 hospital stays with the percentages of 3461 questions on

299 ng (OR = 0.6, 95% = CI 0.5-0.8), and shorter hospital stay (WMD = -3 days, 95% CI = -5 to -2).

300 .75], p < 0.00001) and shorter postoperative hospital stay (WMD: -2.36 [-3.06 to -1.66] d, p < 0.0000